Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Adicionar filtros








Intervalo de ano
1.
Clinical Psychopharmacology and Neuroscience ; : 70-72, 2017.
Artigo em Inglês | WPRIM | ID: wpr-41574

RESUMO

Wolfram syndrome is a relatively unexplored entity in clinical psychiatry. Historically, the discovery of a specific WFS1 gene had generated huge fanfare regarding specific genetic causations of psychiatric disorders. While the initial enthusiasm has faded now, association of Wolfram syndrome with psychiatric illnesses like schizophrenia, psychosis and suicidal behavior still remain important for understanding biological underpinnings of such disorders. We report a case of Wolfram syndrome presenting with multiple manic episodes, discuss possible genetic underpinnings for the affective symptoms and then discuss certain issues regarding management.


Assuntos
Sintomas Afetivos , Transtorno Bipolar , Comorbidade , Transtornos Psicóticos , Esquizofrenia , Síndrome de Wolfram
2.
Clinical Psychopharmacology and Neuroscience ; : 311-313, 2016.
Artigo em Inglês | WPRIM | ID: wpr-108189

RESUMO

Dermatitis artefacta lies in a gray zone, between the specialities of psychiatry and dermatology. The condition could mimic a number of other lesions and therefore is a source of much confusion in clinical practice. Here, we describe a case of dermatitis artefacta in an 11-years old girl, which resembled self-harming behavior in Borderline personality disorder. We then discuss how the two could be differentiated and why this becomes imperative while dealing with such cases.


Assuntos
Feminino , Humanos , Transtorno da Personalidade Borderline , Dermatite , Dermatologia , Comportamento Autodestrutivo , Pele
3.
Clinical Psychopharmacology and Neuroscience ; : 222-223, 2015.
Artigo em Inglês | WPRIM | ID: wpr-121251

RESUMO

No abstract available.


Assuntos
Paroxetina
4.
Clinical Psychopharmacology and Neuroscience ; : 316-318, 2015.
Artigo em Inglês | WPRIM | ID: wpr-209620

RESUMO

While fluoxetine (FXT) is a frequently prescribed selective serotonin reuptake inhibitor (SSRI), with few major side-effects; altered serotonergic transmissions in hypothalamic pathways might lead to a distressing, and often embarrassing, manifestation of galactorrhea by altering prolactin release in those on FXT. We report here a case of FXT-induced hyperprolactinemic galactorrhea developing late into treatment on a stable regimen, who responded well to subsequent replacement with sertraline. Based on present finding, we suggest that while SSRIs may share similar mechanisms of action, there exist individual differences in their effects on prolactin secretion pathways.


Assuntos
Feminino , Gravidez , Fluoxetina , Galactorreia , Hiperprolactinemia , Individualidade , Transtorno Obsessivo-Compulsivo , Prolactina , Via Secretória , Serotonina , Inibidores Seletivos de Recaptação de Serotonina , Sertralina
5.
Clinical Psychopharmacology and Neuroscience ; : 327-327, 2015.
Artigo em Inglês | WPRIM | ID: wpr-209616

RESUMO

No abstract available.


Assuntos
Doença de Alzheimer , Países em Desenvolvimento , Prevenção Primária
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA